Growth Metrics

LifeStance Health (LFST) Cash from Financing Activities (2020 - 2025)

LifeStance Health (LFST) has disclosed Cash from Financing Activities for 6 consecutive years, with -$1.9 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities rose 52.94% to -$1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$16.0 million through Dec 2025, down 60.4% year-over-year, with the annual reading at -$16.0 million for FY2025, 60.4% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$1.9 million at LifeStance Health, up from -$2.0 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $30.8 million in Q4 2023, with the low at -$15.2 million in Q4 2021.
  • Average Cash from Financing Activities over 5 years is $4.2 million, with a median of -$1.9 million recorded in 2023.
  • The sharpest move saw Cash from Financing Activities skyrocketed 183.49% in 2022, then tumbled 310.32% in 2025.
  • Over 5 years, Cash from Financing Activities stood at -$15.2 million in 2021, then surged by 183.49% to $12.7 million in 2022, then soared by 143.53% to $30.8 million in 2023, then crashed by 113.16% to -$4.1 million in 2024, then skyrocketed by 52.94% to -$1.9 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at -$1.9 million, -$2.0 million, and -$2.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.